glp 1 agonist zepbound GLP-1 weight-loss drugs: PA, NJ poison control centers see more calls As Insurers Struggle With GLP-1

Tirzepatide), metabolic outcomes, and next-gen weight loss benefits

While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives

The Revolutionary Role of GLP-1 Agonists and SGLT-2 Inhibitors in Managing Diabetes and Chronic Kidney Disease Shankar Chakkera, Elizabeth J

Among incretin-based drugs, glucagon-like peptide 1 (GLP-1) receptor agonists are a ...

This is the unlikely journey from desert predator to medical marvel.

National Taiwan University researchers highlight the benefits of GLP-1 receptor agonists (GLP-1 RAs) in reducing mortality and severe cardiovascular and renal outcomes for diabetic patients with acute kidney disease (AKD)